<?xml version="1.0" encoding="UTF-8"?>
<MedicationAdministration
    xmlns="http://hl7.org/fhir">
    <id value="medicationadministration-dulaglutide"/>
    <meta>
        <versionId value="1"/>
        <lastUpdated value="2021-01-13T08:58:31.809+00:00"/>
        <source value="#7qglfCl0FOzcVohi"/>
        <profile value="http://hl7.org/fhir/us/ade-hypo/StructureDefinition/MedicationAdministration-Antidiabetics"/>
    </meta>
    <status value="completed"/>
    <medicationCodeableConcept>
        <coding>
            <system value="http://www.nlm.nih.gov/research/umls/rxnorm"/>
            <code value="1043563"/>
            <display value="24 HR metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet"/>
        </coding>
        <text value="24 HR metformin hydrochloride 1000 MG / saxagliptin 2.5 MG Extended Release Oral Tablet"/>
    </medicationCodeableConcept>
    <subject>
        <reference value="Patient/patient-ade-1"/>
    </subject>
    <effectivePeriod>
        <start value="2020-04-08"/>
        <end value="2018-04-08"/>
    </effectivePeriod>
    <dosage>
        <route>
            <coding>
                <system value="http://snomed.info/sct"/>
                <code value="26643006"/>
                <display value="Oral Route"/>
            </coding>
        </route>
        <method>
            <coding>
                <system value="http://snomed.info/sct"/>
                <code value="421521009"/>
                <display value="Swallow - dosing instruction imperative (qualifier value)"/>
            </coding>
        </method>
        <dose>
            <value value="2"/>
            <unit value="TAB"/>
            <system value="http://terminology.hl7.org/CodeSystem/v3-orderableDrugForm"/>
            <code value="TAB"/>
        </dose>
    </dosage>
</MedicationAdministration>